.jpg)
Columbia University
Mishaela Rubin obtained her MD degree at Columbia University’s Vagelos College of Physicians & Surgeons in 1995. She went on to complete her residency in Medicine and her fellowship in Endocrinology at Columbia and has been on the faculty there since 2002. Dr. Rubin also obtained a Masters degree at Columbia’s Mailman School of Public Health in Biostatistics. She is currently an Associate Professor in the Department of Medicine at Columbia and sees patients and conducts research in the Division of Endocrinology’s Metabolic Bone Disease Unit. Dr. Rubin studies hypoparathyroidism and has published studies characterizing the clinical, biochemical and skeletal features of patients with this disease. She has led clinical trials sponsored by the NIH and by industry to treat hypoparathyroid patients with parathyroid hormone therapy. She is currently conducting an NIH-funded study to develop a continuous calcium sensor skin patch for hypoparathyroid patients. She is also leading an FDA-funded study to investigate the natural history of hypoparathyroidism. Dr. Rubin also studies diabetic bone disease and has conducted studies of the structural, dynamic and material alterations in the skeleton of type 2 diabetes patients. She led an NIH-sponsored clinical trial to investigate the skeletal effects of blocking advanced glycation endproduct accumulation in postmenopausal women with type 2 diabetes. Dr. Rubin is also focused on bone health in type 1 diabetes patients. She is a co-investigator in the Skeletal Health study of the long-term DCCT/EDIC study of type 1 diabetes patients. She is also leading an NIH-funded study characterizing the longitudinal changes in bone microarchitecture of type 1 diabetes children as they undergo peak bone accrual.
Friday, May 5, 2023
1:00 PM – 1:15 PM